全文获取类型
收费全文 | 202篇 |
免费 | 41篇 |
专业分类
儿科学 | 4篇 |
基础医学 | 12篇 |
临床医学 | 5篇 |
内科学 | 21篇 |
皮肤病学 | 2篇 |
特种医学 | 4篇 |
外科学 | 119篇 |
综合类 | 10篇 |
预防医学 | 48篇 |
药学 | 17篇 |
中国医学 | 1篇 |
出版年
2023年 | 9篇 |
2022年 | 11篇 |
2021年 | 26篇 |
2020年 | 22篇 |
2019年 | 20篇 |
2018年 | 23篇 |
2017年 | 15篇 |
2016年 | 16篇 |
2015年 | 10篇 |
2014年 | 15篇 |
2013年 | 9篇 |
2012年 | 9篇 |
2011年 | 12篇 |
2010年 | 12篇 |
2009年 | 11篇 |
2008年 | 6篇 |
2007年 | 4篇 |
2006年 | 2篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2003年 | 1篇 |
2000年 | 1篇 |
1995年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1989年 | 2篇 |
1984年 | 1篇 |
排序方式: 共有243条查询结果,搜索用时 15 毫秒
1.
Jin Ge Emily R. Perito John Bucuvalas Richard Gilroy Evelyn K. Hsu John P. Roberts Jennifer C. Lai 《American journal of transplantation》2020,20(4):1116-1124
Split liver transplantation (SLT) is 1 strategy for maximizing the number of deceased donor liver transplants. Recent reports suggest that utilization of SLT in the United States remains low. We examined deceased donor offers that were ultimately split between 2010 and 2014. SLTs were categorized as “primary” and “secondary” transplants. We analyzed allocation patterns and used logistic regression to evaluate factors associated with secondary split discard. Four hundred eighteen livers were split: 54% from adult, 46% from pediatric donors. Of the 227 adult donor livers split, 61% met United Network for Organ Sharing “optimal” split criteria. A total of 770 recipients (418 primary and 352 secondary) were transplanted, indicating 16% discard. Ninety‐two percent of the 418 primary recipients were children, and 47% were accepted on the first offer. Eighty‐seven percent of the 352 secondary recipients were adults, and 7% were accepted on the first offer. Of the 352 pairs, 99% were transplanted in the same region, 36% at the same center. In logistic regression, shorter donor height was associated with secondary discard (odds ratio 0.97 per cm, 95% CI 0.94‐1.00, P = .02). SLT volume by center was not predictive of secondary discard. Current policy proposals that incentivize SLT in the United States could increase the number of transplants to children and adults. 相似文献
2.
目的:为完善我国各省药品集中采购工作提供建议。方法:检索收集2015年各省药品集中采购最新文件,采用文献分析、对比分析和实地调研访谈等方法进行归纳总结。结果:各省落实7号文和70号文开展药品集中采购工作时,在组织机构、分类采购、带量采购、药品配送与回款等方面存在差异。结论:各省应坚持集中招标采购,探索医保部门参与药品集中采购新方式;落实三医联动;破除地方保护主义,保障药品集中采购工作顺利、公平进行。 相似文献
3.
4.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(11):1994-2005
BackgroundSocio-economic inequalities among different racial/ethnic groups have increased in many high-income countries. It is unclear, however, whether increasing socio-economic inequalities are associated with increasing differences in survival in liver transplant (LT) recipients.MethodsAdults undergoing first time LT for hepatocellular carcinoma (HCC) between 2002 and 2017 recorded in the Scientific Registry of Transplant Recipients (SRTR) were included and grouped into three cohorts. Patient survival and graft survival stratified by race/ethnicity were compared among the cohorts using unadjusted and adjusted analyses.ResultsWhite/Caucasians comprised the largest group (n=9,006, 64.9%), followed by Hispanic/Latinos (n=2,018, 14.5%), Black/African Americans (n=1,379, 9.9%), Asians (n=1,265, 9.1%) and other ethnic/racial groups (n=188, 1.3%). Compared to Cohort I (2002-2007), the 5-year survival of Cohort III (2012-2017) increased by 18% for Black/African Americans, by 13% for Whites/Caucasians, by 10% for Hispanic/Latinos, by 9% for patients of other racial/ethnic groups and by 8% for Asians (All P values<0.05). Despite Black/African Americans experienced the highest survival improvement, their overall outcomes remained significantly lower than other ethnic∕racial groups (adjusted HR for death=1.20; 95%CI 1.05-1.36; P=0.005; adjusted HR for graft loss=1.21; 95%CI 1.08-1.37; P=0.002).ConclusionThe survival gap between Black/African Americans and other ethnic/racial groups undergoing LT for HCC has significantly decreased over time. However, Black/African Americans continue to have the lowest survival among all racial/ethnic groups. 相似文献
5.
This paper investigates the price variability of standardized medical devices purchased by Italian Public Buyers (PBs). A semiparametric approach is used to recover the marginal cost of each device. Average prices vary substantially between PBs; we show that most of the difference between the purchase prices and estimated costs is associated with a PB fixed effect, which, in turn, is related to the institutional characteristics and size of the PB. Repeating the main estimation using device fixed effects yields similar results. Finally, an exogenous policy change, i.e. the termination of the mandatory reference price regime, is used to assess how discretion affects medical device procurement given the skills of each PB. Our results show that less PB discretion — i.e. when mandatory reference prices apply — determines efficiency gains and losses for low- and high-skilled PBs, respectively. 相似文献
6.
Christine E. Haugen Tanveen Ishaque Abel Sapirstein Alexander Cauneac Dorry L. Segev Sommer Gentry 《American journal of transplantation》2019,19(7):2044-2052
Recent OPTN proposals to address geographic disparity in liver allocation have involved circular boundaries: the policy selected 12/17 allocated to 150‐mile circles in addition to DSAs/regions, and the policy selected 12/18 allocated to 150‐mile circles eliminating DSA/region boundaries. However, methods to reduce geographic disparity remain controversial, within the OPTN and the transplant community. To inform ongoing discussions, we studied center‐level supply/demand ratios using SRTR data (07/2013‐06/2017) for 27 334 transplanted deceased donor livers and 44 652 incident waitlist candidates. Supply was the number of donors from an allocation unit (DSA or circle), allocated proportionally (by waitlist size) to the centers drawing on these donors. We measured geographic disparity as variance in log‐transformed supply/demand ratio, comparing allocation based on DSAs, fixed‐distance circles (150‐ or 400‐mile radius), and fixed‐population (12‐ or 50‐million) circles. The recently proposed 150‐mile radius circles (variance = 0.11, P = .9) or 12‐million‐population circles (variance = 0.08, P = .1) did not reduce the geographic disparity compared to DSA‐based allocation (variance = 0.11). However, geographic disparity decreased substantially to 0.02 in both larger fixed‐distance (400‐mile, P < .001) and larger fixed‐population (50‐million, P < .001) circles (P = .9 comparing fixed distance and fixed population). For allocation circles to reduce geographic disparities, they must be larger than a 150‐mile radius; additionally, fixed‐population circles are not superior to fixed‐distance circles. 相似文献
7.
Defne A. Magnetta Justin Godown Shawn West Matthew Zinn Kirsten Rose‐Felker Susan Miller Brian Feingold 《American journal of transplantation》2019,19(12):3276-3283
US Pediatric Heart Allocation Policy was recently revised, deprioritizing candidates with cardiomyopathy while maintaining status 1A eligibility for congenital heart disease (CHD) candidates on “high‐dose” inotropes. We compared waitlist characteristics and mortality around this change. Status 1A listings decreased (70% to 56%, P < .001) and CHD representation increased among status 1A listings (48% vs 64%, P < .001). Waitlist mortality overall (subdistribution hazard ratio [SHR] 0.96, P = .63) and among status 1A candidates (SHR 1.16, P = .14) were unchanged. CHD waitlist mortality trended better (SHR 0.82, P = .06) but was unchanged for CHD candidates listed status 1A (SHR 0.92, P = .47). Status 1A listing exceptions increased 2‐ to 3‐fold among hypertrophic and restrictive cardiomyopathy candidates and 13.5‐fold among dilated cardiomyopathy (DCM) candidates. Hypertrophic (SHR 6.25, P = .004) and restrictive (SHR 3.87, P = .03) cardiomyopathy candidates without status 1A exception had increased waitlist mortality, but those with DCM did not (SHR 1.26, P = .32). Ventricular assist device (VAD) use increased only among DCM candidates ≥1 years old (26% vs 38%, P < .001). Current allocation policy has increased CHD status 1A representation but has not improved their waitlist mortality. Excessive DCM status 1A listing exceptions and continued status 1A prioritization of children on stable VADs potentially diminish the intended benefits of policy revision. 相似文献
8.
9.
10.
Rebecca R. Goff Amber R. Wilk Alice E. Toll Maureen A. McBride David K. Klassen 《American journal of transplantation》2021,21(6):2100-2112
COVID-19 has been sweeping the globe, hitting the United States particularly hard with a state of emergency declared on March 13, 2020. Transplant hospitals have taken various precautions to protect patients from potential exposure. OPTN donor, candidate, and transplant data were analyzed from January 5, 2020 to September 5, 2020. The number of new waiting list registrations decreased, with the Northeast seeing over a 50% decrease from the week of 3/8 versus the week of 4/5. The national transplant system saw near cessation of living donor transplantation (−90%) from the week of 3/8 to the week of 4/5. Similarly, deceased donor kidney transplant volume dropped from 367 to 202 (−45%), and other organs saw similar decreases: lung (−70%), heart (−43%), and liver (−37%). Deceased donors recovered dropped from 260 to 163 (−45%) from 3/8 compared to 4/5, including a 67% decrease for lungs recovered. The magnitude of this decrease varied by geographic area, with the largest percent change (−67%) in the Northeast. Despite the pandemic, discard rates across organ has remained stable. Although the COVID-19 pandemic continues to evolve, OPTN data show recent evidence of stabilization, an indication that an early recovery of the number of living and deceased donors and transplants has ensued. 相似文献